Medical News

RSS

Biologic therapies do not increase risk of cancer in patients with rheumatoid arthritis

Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.

6 Sep 2012

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.

6 Sep 2012

Viewpoints: Anti-abortion Democrats praise health law; A defense of the Medicare cost-cutting board

The big question heading into the Democratic Convention is just how forcefully the party will defend the Affordable Care Act, which the president fought to pass and then declined to sell. On Tuesday, an unusually vocal endorsement of the law came from an unlikely source: Anti-abortion Democrats.

6 Sep 2012

UEA, IFR to study protective effects of broccoli consumption against prostate cancer

The Prostate Cancer Foundation is providing $1M of funding to the Institute of Food Research and the University of East Anglia (UEA) to study the protective effects of broccoli consumption against prostate cancer.

6 Sep 2012

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors still suffer acute graft-versus-host disease (GVHD).

6 Sep 2012

Endovascular repair for abdominal aortic aneurysms has low rate of complications

A minimally invasive procedure known as endovascular repair used for abdominal aortic aneurysms has a low rate of complications, even in high-risk patients such as those with kidney, heart or lung problems, a Mayo Clinic study shows.

6 Sep 2012

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.

6 Sep 2012

Medicare beneficiaries who were overcharged for drugs because of CVS' incorrect prices will receive refunds

The Federal Trade Commission said that it is mailing refund checks to 13,000 Medicare Part D beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the medications.

6 Sep 2012

Hendricks Regional Health implements Heart IT's WebPAX to help manage cardiac images

Heart IT, the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, has joined Hendricks Regional Health to announce the implementation of Heart IT's WebPAX platform to help manage and distribute cardiac images.

6 Sep 2012

TSC and PTEN genes important in controlling blood precursor cells in Drosophila

UCLA stem cell scientists have shown that two common tumor suppressor genes, TSC and PTEN, are vital to regulating the stem cell-like precursor cells that create the blood supply in Drosophila, the common fruit fly.

6 Sep 2012

Developing countries NGO delegation to Global Fund submits report highlighting challenges, recommendations

The Center for Global Health Policy's "Science Speaks" blog discusses a report by the developing countries NGO delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, submitted recently to the Global Fund Secretariat.

6 Sep 2012

Nordion third quarter revenue increases 0.5% to $67.1 million

Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.

6 Sep 2012

DuraSite 2 ophthalmic drug delivery system from InSite Vision

InSite Vision Incorporated today introduced DuraSite 2, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics.

6 Sep 2012

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today complete results from its Phase IIb trial with ALN-RSV01 for the treatment of respiratory syncytial virus (RSV) infection in lung transplant patients.

6 Sep 2012

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

Disease-free survival for invasive ductal breast cancer (IDC) patients may be easier to predict with the help of F-18-fludeoxyglucose positron emission tomography (PET)/computed tomography (CT) scans, according to research published in the September issue of The Journal of Nuclear Medicine. New data show that high maximum standard uptake value (SUVmax) of F-18-FDG in the lymph nodes prior to treatment could be an independent indicator of disease recurrence.

6 Sep 2012

LIN28 protein can bind directly to thousands of messenger RNAs

A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases.

6 Sep 2012

Two UNC autism researchers receive $12.6 million in grants from ACE program

Two autism researchers in the University of North Carolina School of Medicine have each been awarded $12.6 million grants in the latest round of funding from the National Institutes of Health's Autism Centers of Excellence (ACE) research program.

6 Sep 2012

Janssen receives FDA Priority Review for bedaquiline NDA to treat MDR-TB

Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.

6 Sep 2012

Tips to deal with bed bugs when traveling

As VIPs come to Charlotte, N.C., for the Democratic National Convention, some are being greeted by undesirable guests in their hotels. No, not protesters. Bed bugs. Reports of the little blood-suckers have been on the uptick in Charlotte, and they are a growing problem in the lodging industry throughout the country. The good news: Delegates, and anyone who travels, can take precautions against bed bugs—small insects that feed on human blood and are usually active at night when people are sleeping.

6 Sep 2012

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.

6 Sep 2012

Medical News

Biologic therapies do not increase risk of cancer in patients with rheumatoid arthritis

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Viewpoints: Anti-abortion Democrats praise health law; A defense of the Medicare cost-cutting board

UEA, IFR to study protective effects of broccoli consumption against prostate cancer

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

Endovascular repair for abdominal aortic aneurysms has low rate of complications

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

Medicare beneficiaries who were overcharged for drugs because of CVS' incorrect prices will receive refunds

Hendricks Regional Health implements Heart IT's WebPAX to help manage cardiac images

TSC and PTEN genes important in controlling blood precursor cells in Drosophila

Developing countries NGO delegation to Global Fund submits report highlighting challenges, recommendations

Nordion third quarter revenue increases 0.5% to $67.1 million

DuraSite 2 ophthalmic drug delivery system from InSite Vision

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

LIN28 protein can bind directly to thousands of messenger RNAs

Two UNC autism researchers receive $12.6 million in grants from ACE program

Janssen receives FDA Priority Review for bedaquiline NDA to treat MDR-TB

Tips to deal with bed bugs when traveling

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News